Pharmacogenomics: Identification of New Drug Targets
Lipids as Anchors
Overview of Lipid Metabolism
Transducer Mechanism: Enzyme-Linked Receptors
PI3K/mTOR/AKT Signaling Pathway
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 24, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
1Cell Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 143, New York, NY 10065, USA. m-resh@ski.mskcc.org
Lipid modifications like myristoylation and prenylation regulate proteins. Inhibitors targeting these processes show potential for treating infectious diseases, cancer, and rare aging syndromes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: